QQQ

DIA

SPY

TLT

GLD

BTC/USD

QQQ

DIA

SPY

TLT

GLD

BTC/USD

Field Trip Health

Field Trip Health To Divide Into Two Separate Public Companies

Field Trip Health To Divide Into Two Separate Public Companies

Field Trip Health (NASDAQ: FTRP) will divide two of its divisions into public companies of their own.

Apr 29, 2022, 11:04 AM

Ketamine Rapidly Reduces Depression, According To 'Most Comprehensive Review' Of Evidence — But Patient Experiences Suggest More Applications

Ketamine Rapidly Reduces Depression, According To 'Most Comprehensive Review' Of Evidence — But Patient Experiences Suggest More Applications

This article was originally published on Psychedelic Spotlight and appears here with permission.

Jan 29, 2022, 12:29 PM

Understanding The Psilocybin Supply Chain: Every Production Method Explained

Understanding The Psilocybin Supply Chain: Every Production Method Explained

Psilocybin is known as the active compound in so-called “magic mushrooms”, yet most psilocybin used in clinical trials today is synthesized in laboratories without the use of biological material. As psychedelics-assisted therapy gains momentum, investors need to understand the difference between the current available means of obtaining psilocybin.

Jan 3, 2022, 1:01 PM

Psychedelic Companies Keenly Aware Of Creating Therapies As Healthcare Reimbursement Possibility Looms

Psychedelic Companies Keenly Aware Of Creating Therapies As Healthcare Reimbursement Possibility Looms

In the quest to design effective and affordable psychedelic treatments for a range of maladies that include PTSD and depression, one key thought on the minds of company executives and clinicians alike seems to be how to motivate healthcare insurance companies to cover the cost of psychedelic therapies.

Nov 22, 2021, 2:20 PM

Psyched: Novamind Partners With Merck, Atai Expands To Japan, Australia Funds Psychedelics Research

Psyched: Novamind Partners With Merck, Atai Expands To Japan, Australia Funds Psychedelics Research

Novamind Strikes Research Deal With Merck

Mar 22, 2021, 9:09 AM